Teleflex Inc. (TFX) Names Richard 'Randy' Meier to EVP and CFO
Up)
Teleflex Incorporated (NYSE: TFX) has announced the appointment of Richard (Randy) Meier as executive vice president and chief financial officer, effective the close of business today. Mr. Meier was previously president and chief operating officer of Advanced Medical Optics, Inc., a publicly-traded $1.2 billion global ophthalmic medical device company.
"Randy brings a depth of experience to the chief financial officer role, with more than 10 years of financial and operational leadership in medical device and pharmaceutical companies," said Jeffrey P. Black, Teleflex chairman and chief executive officer. "His proven track record leading high performance, fast-growth organizations is a great addition to our team as we execute on our strategic initiatives."
Added Black, "Randy has demonstrated strong financial acumen and a commitment to maintaining solid financial fundamentals and operational effectiveness programs while building organizations that can deliver consistent revenue growth through targeted acquisitions and organic growth initiatives. We look forward to his future contributions at Teleflex."
Mr. Meier succeeds Kevin K. Gordon who, as previously announced, is leaving Teleflex this month after 13 years with the company.
Mr. Meier is currently a member of the board of directors of BioMarin Pharmaceuticals, Inc. and Staar Surgical Co. He was an executive with Advanced Medical Optics, Inc. (NYSE: EYE) from 2002 until the company was acquired in 2009. He served as executive vice president and chief financial officer of Valeant Pharmaceuticals, Inc. (NYSE: VRX) from 1999-2002.
"Randy brings a depth of experience to the chief financial officer role, with more than 10 years of financial and operational leadership in medical device and pharmaceutical companies," said Jeffrey P. Black, Teleflex chairman and chief executive officer. "His proven track record leading high performance, fast-growth organizations is a great addition to our team as we execute on our strategic initiatives."
Added Black, "Randy has demonstrated strong financial acumen and a commitment to maintaining solid financial fundamentals and operational effectiveness programs while building organizations that can deliver consistent revenue growth through targeted acquisitions and organic growth initiatives. We look forward to his future contributions at Teleflex."
Mr. Meier succeeds Kevin K. Gordon who, as previously announced, is leaving Teleflex this month after 13 years with the company.
Mr. Meier is currently a member of the board of directors of BioMarin Pharmaceuticals, Inc. and Staar Surgical Co. He was an executive with Advanced Medical Optics, Inc. (NYSE: EYE) from 2002 until the company was acquired in 2009. He served as executive vice president and chief financial officer of Valeant Pharmaceuticals, Inc. (NYSE: VRX) from 1999-2002.
You May Also Be Interested In
- Valeant Pharmaceuticals Agrees to Acquire Certain Assets from Swiss Herbal
- Martha Stewart Living Omnimedia (MSO) Names Martha Stewart as Non-Executive Chairman
- Sealed Air (SEE) Names Carol Lowe as Senior VP, CFO
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
